Jeena Sikho Lifecare (JSLL) Q2 25/26 earnings summary

Executive summary

• Q2FY26 revenue from operations was ₹18,984.51 lakh, up 66% YoY; EBITDA margin reached 48% and PAT rose 121% YoY to ₹5,875.01 lakh.

• H1FY26 revenue was ₹36,413.10 lakh and consolidated profit was ₹11,002.15 lakh.

• OPD volumes grew 67% YoY to 2.07 lakh and IPD volumes grew 57% to 17,154; three hospitals opened, taking operational capacity above 2,220 beds.

Financial highlights

• Consolidated Q2 total income was ₹19,129.00 lakh, PBT ₹7,872.67 lakh and PAT ₹5,875.01 lakh; Q2FY25 revenue was ₹11,409.09 lakh and PAT ₹2,659.92 lakh.

• EBITDA was ₹92.06 crore, up 129% YoY; margin was 48%, versus 35% in Q2FY25 and 45% in Q1FY26.

• Gross profit was ₹165.76 crore, with an 87% gross margin; EBIT was ₹81.66 crore, up 140% YoY.

• Consolidated H1 total income was ₹36,664.44 lakh, PBT ₹14,723.65 lakh and PAT ₹11,002.15 lakh.

Outlook and guidance

• Priorities include improving utilization of existing assets, opening new centres and adding beds at existing facilities.

• Plans include expanding the OTC channel, launching six additional products during the remainder of the year and widening cashless insurance coverage.

• Overseas expansion is planned, beginning with the UAE; capacity expansion, operational improvements and broader product offerings are expected to support growth.